Lilly Opens Labs, Scientists Pretend To R&D Like Experts
In sunny San Diego, Eli Lilly & Co. puffed out their biotech chest by launching the Gateway Labs incubator, a shiny new playground for science geeks to pretend they understand R&D results. Chief Science Officer Daniel Skovronsky, who sounds like he moonlights as a superhero, held court with broad statements that sound impressively vague about the company’s R&D roadmap. No exact dollar figures, no timelines—just biotech bravado with a coastal breeze. If you were expecting actual breakthroughs, tough luck: it’s more of a 'build it and we hope drugs happen' vibe. Welcome to science startups, where buzzwords flow freer than lab coffee.
Share the Story
Nothing says breakthrough biotech like an official opening where the top scientist talks about broad R&D plans in San Diego and the real science is guessing what those plans actually are. Spoiler: we’re all terrible drivers of our own life projects.
Daniel Skovronsky officially announced the biotech incubator and a vague plan to do more biotech things. San Diego’s science scene now has a shiny sign and no actual new drugs, yet.
Welcome to Eli Lilly’s Gateway Labs: where science gets a beachfront address, a nebulous R&D pitch, and all the optimism of your 'new year, new me' resolutions.
Source: Statnews | Published: 9/30/2025 | Author: Jonathan Wosen
More Articles in Science
Meet The Ocean’s 3.5-Year Pregnant Frilled Shark & Friends
Orionids Fireballs Crash Earth’s Sky Party, No RSVP Needed
Canada's Fridge-Sized Peat Storage Threatened By Metal-Hungry Miners
Zombie Bugs Hijack Brains, Outperform Your Last Zoom Call
Bill Nye vs. Trump’s 47% NASA Killjoy Cut: Space Showdown
